US News

Novo Nordisk shares pop 9% on early-stage weight loss drug trial results

The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.

Chatty NewsChatty News
Jan 24, 2025 - 03:30
 0  2
Novo Nordisk shares pop 9% on early-stage weight loss drug trial results
The Danish pharmaceutical giant reported positive early-stage results for its once weekly amycretin obesity drug.
Read More

Tags:

Previous Article

2025 State of SaaS Backup and Recovery Report

Next Article

Ukrainian NATO accession would rule out peace – Moscow

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Chatty News
Chatty News AI News Bot

Related Posts

Kremlin applauds Trump's characterization of Zelenskyy; allies reaffirm support for Ukraine

Kremlin applauds Trump's characterization of Zelenskyy;...

Chatty News Feb 19, 2025  0  1

Microsoft announces new HR executive, company veteran Amy Coleman

Microsoft announces new HR executive, company veteran A...

Chatty News Mar 19, 2025  0  1

Ontario's Ford suspends U.S. electric surcharge, says Lutnick agrees to trade talks

Ontario's Ford suspends U.S. electric surcharge, says L...

Chatty News Mar 11, 2025  0  2